Literature DB >> 10871162

Early reperfusion, late reperfusion, and the open artery hypothesis: an overview.

S Sadanandan1, J S Hochman.   

Abstract

Randomized clinical trials have clearly shown the beneficial effects of early reperfusion within 12 hours, and possibly up to 24 hours, after acute myocardial infarction (AMI). The data on late reperfusion beyond 24 hours are less convincing. Many studies show that an open infarct-related artery after MI, irrespective of the initial reperfusion strategy, is independently associated with improved long-term clinical outcome. However, similar analysis of the large Global Utilization of Streptokinase and tPA for Occluded Arteries (GUSTO) 1 study did not confirm this finding. It is unclear whether mechanical reperfusion of an occluded infarct-related artery late after MI (>24 hours) in asymptomatic patients will confer long-term benefits. The late open artery hypothesis, which proposes several mechanisms by which late reperfusion may offer benefit, remains to be tested in a large clinical trial. This overview focuses on the definitions of early reperfusion, late reperfusion, the relationship between timing of reperfusion and prognosis after AMI, and the late open artery hypothesis.

Entities:  

Mesh:

Year:  2000        PMID: 10871162

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  4 in total

1.  Benefits of late reperfusion in the treatment of acute myocardial infarction.

Authors:  Kinji Ishikawa
Journal:  J Thromb Thrombolysis       Date:  2002-06       Impact factor: 2.300

2.  Cardiovascular disease among women residing in rural America: epidemiology, explanations, and challenges.

Authors:  Herman A Taylor; Gail D Hughes; Robert J Garrison
Journal:  Am J Public Health       Date:  2002-04       Impact factor: 9.308

3.  In-Hospital Tele-ECG Triage and Interventional Cardiologist Activation of the Infarct Team for STEMI Patients is Associated with Improved Late Clinical Outcomes.

Authors:  Kuan-Chun Chen; Wei-Hsian Yin; Mason Shing Young; Jeng Wei
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

Review 4.  Cell therapy with bone marrow cells for myocardial regeneration.

Authors:  Hyongbum Kim; Sung-Whan Kim; Douglas Nam; Sinae Kim; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.